Search
for
Sort by
Research 211–240 of 734
- Androgens in women
- Debatable Topics in PCOS Patients
- Adult polycystic ovary syndrome begins in childhood
- High-sensitivity C-reactive protein (hs-CRP) levels and its relationship with components of polycystic ovary syndrome in Indian adolescent women with polycystic ovary syndrome (PCOS)
- Testosterone in Women: Measurement and Therapeutic Use
- Polycystic Ovary Syndrome: Features, Diagnostic Criteria and Treatments
- Variations in alanine aminotransferase levels within the normal range predict metabolic and androgenic phenotypes in women of reproductive age
- An update on diagnosis and treatment of female pattern hair loss
- Role of plasminogen activator inhibitor type 1 (PAI-1) in PCOS patient
- Polycystic Ovary Syndrome-Associated Acne: The Interplay of Hyperandrogenism, Insulin Resistance, and Therapeutic Strategies
- Polycystic ovarian syndrome
- Polycystic Ovary Syndrome in Adolescents
- Diagnostic approach to low‐renin hypertension
- Controversies in Polycystic Ovary Syndrome
- The role of androgen and androgen receptor in skin-related disorders
- The mineralocorticoid receptor as a novel player in skin biology: beyond the renal horizon?
- Neuroendocrine Controls of Keratin Expression in Human Skin
- Polycystic Ovarian Syndrome
- Polycystic Ovary Syndrome: A Common But Often Unrecognized Condition
- Gynecologic and andrologic dermatology and the metabolic syndrome
- Adult Acne: Prevalence and Portrayal in Primary Healthcare Patients, in the Greater Porto Area, Portugal
- Skin as a Window to Endocrine Dysfunction: Dermatological and Metabolic Interactions in Polycystic Ovary Syndrome
- Metabolic Aspects of Polycystic Ovary Syndrome
- Metabolic Aspects of Polycystic Ovary Syndrome
- Workup and Management of Polycystic Ovary Syndrome
- Androgen Secreting Steroid Cell Tumor of the Ovary Represented with Postmenopasal Bleeding and Extensive Hirsutism
- A review of diagnosis and treatment of acne in adult female patients
- How should postmenopausal androgen excess be evaluated?
- 17-Hydroxyprogesterone Responses to Gonadotropin-Releasing Hormone Disclose Distinct Phenotypes of Functional Ovarian Hyperandrogenism and Polycystic Ovary Syndrome
- Understanding Polycystic Ovary Syndrome